Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Find out about how philanthropy supports our research, learn about our Enterprise Unit and see details of our latest PhD studentship opportunities.

New PhD studentship opportunties

We’re searching for the brightest minds in cancer research. The deadline for applications for our latest PhD recruitment round is on Sunday 17 November.
Find out more
Informatics at the ICR

Cancer is a complex, ever-changing set of diseases. To truly understand and beat cancer, we must have a comprehensive view of all its facets. New technologies allow us to gather data on all these views of cancer at scale.
Read more
Let’s finish it: Centre for Cancer Drug Discovery Appeal

We are creating a new state-of-the art drug discovery centre to create more and better drugs for cancer patients. The centre is a £75m build – and we now have less than £14m to raise. To make our building a reality, we urgently need your philanthropic support.
Support us
Men over 40 with BRCA2 gene fault ‘should get regular PSA screening’

Guidelines should change so that all men over the age of 40 with faults in the BRCA2 gene should be offered regular PSA testing to detect early signs of prostate cancer, experts are urging.
Read more
NCRI 2019

The National Cancer Research Institute (NCRI) Cancer Conference is the UK's largest meeting of cancer researchers and doctors. In 2019, the conference was held in Glasgow from 3-5 November and, as always, the ICR attended.
Read more

1/5

Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Find out more
Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Find out more
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Find out more
Making it count

We will deliver better outcomes and improved quality of life for patients by establishing innovative treatments, diagnostics and strategies for prevention as part of routine healthcare.
Find out more
Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Find out more
Winner of Queen's Anniversary Prize

The ICR has been recognised with a highly prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Read more